Acadia Healthcare Company Inc. Common Stock (NASDAQ: ACHC)
The Complaint alleges that throughout and before the Class Period, defendants made materially false and misleading statements and omissions regarding Acadia’s business and operations. Specifically, defendants falsely stated that the quality of Acadia’s U.K. operations gave it a “competitive strength” that would drive future growth and profitability. In addition, defendants caused Acadia to issue false and misleading guidance regarding the Company’s actual and projected fiscal 2017 revenue, earnings before interest, taxes, depreciation and amortization (“EBITDA”) and earnings per share (“EPS”).